Yahoo
ASX - Delayed Quote AUD

Little Green Pharma Ltd (LGP.AX)

0.0600 +0.0040 (+7.14%)
At close: October 30 at 3:06:01 PM GMT+11
Chart Range Bar
Loading chart for LGP.AX
  • Previous Close 0.0560
  • Open 0.0570
  • Bid 0.0580 x --
  • Ask 0.0600 x --
  • Day's Range 0.0570 - 0.0600
  • 52 Week Range 0.0560 - 0.1400
  • Volume 358,462
  • Avg. Volume 200,778
  • Market Cap (intraday) 49.679M
  • Beta (5Y Monthly) 0.30
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 0.15

Little Green Pharma Ltd produces and sells cannabis-based medicinal products across Australia and Europe. The company also provides infrastructure to support plant genetics programs and the development of its flower portfolio. It sells its products through a network of wholesalers, pharmacies, clinics, and GPs (general practitioners). The company was founded in 2016 and is based in Wembley, Australia.

www.littlegreenpharma.com

--

Full Time Employees

June 30

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

LGP.AX
52.00%
S&P/ASX 200 [XJO] (^AXJO)
2.22%

1-Year Return

LGP.AX
53.85%
S&P/ASX 200 [XJO] (^AXJO)
0.29%

3-Year Return

LGP.AX
61.29%
S&P/ASX 200 [XJO] (^AXJO)
31.37%

5-Year Return

LGP.AX
91.43%
S&P/ASX 200 [XJO] (^AXJO)
21.63%

Analyst Insights

View More

Analyst Price Targets

0.15
0.15 Average
0.0600 Current
0.15 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.23%

  • Return on Assets (ttm)

    8.31%

  • Return on Equity (ttm)

    14.01%

  • Revenue (ttm)

    75.5M

  • Net Income Avi to Common (ttm)

    6.94M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    2.73M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: